Trump Administration Ends Medicaid Coverage for Gender-Affirming Care for Transgender Minors
The Trump administration announced that Medicaid will cease coverage for gender-affirming surgeries and hormone treatments for transgender minors, effective October 13. This policy change also affects the state Children's Health Insurance Program for individuals under 19. While mental health treatment…
Detroit, MI, August 11, 2026 —
The Trump administration has announced a significant policy shift that will end Medicaid coverage for gender-affirming surgeries and hormone treatments for transgender individuals under the age of 19. The change is scheduled to take effect on October 13.
This new policy also impacts the state Children’s Health Insurance Program (CHIP), which provides coverage for children under 19. While coverage for mental health treatment related to gender dysphoria will continue, the administration stated that puberty blockers and hormone treatments for individuals currently receiving them will be phased out by April 2027.
Officials cited concerns regarding the potential for irreversible harm associated with these treatments in minors as the reasoning behind the decision.
In response to the announcement, LGBTQ+ advocates and various legal groups have strongly condemned the move. They characterized the decision as harmful and discriminatory, and several groups have indicated their intention to pursue legal challenges against the policy change.
Story summarized from the original created by Geoff Mulvihill, Associated Press on www.clickondetroit.com, see more information here.
